KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 16,921 Value ($000) $79 Avg Close — Range —
Q3 2017
Shares 281,300 Value ($000) $1,997 Avg Close — Range —
Q2 2017
Shares 169,579 Value ($000) $1,226 Avg Close — Range —
Q1 2017
Shares 126,568 Value ($000) $780 Avg Close — Range —
Q4 2016
Shares 180,271 Value ($000) $1,056 Avg Close — Range —
Q3 2016
Shares 27,683 Value ($000) $147 Avg Close — Range —
Q2 2016
Shares 29,252 Value ($000) $194 Avg Close — Range —
Q1 2016
Shares 260,220 Value ($000) $1,215 Avg Close — Range —
Q4 2015
Shares 157,225 Value ($000) $794 Avg Close — Range —
Q3 2015
Shares 118,561 Value ($000) $417 Avg Close — Range —
Q2 2015
Shares 185,720 Value ($000) $1,853 Avg Close — Range —
Q1 2015
Shares 11,915 Value ($000) $152 Avg Close — Range —
Q4 2014
Shares 88,579 Value ($000) $1,254 Avg Close — Range —
Q3 2014
Shares 54,239 Value ($000) $746 Avg Close — Range —
Q2 2014
Shares 33,588 Value ($000) $517 Avg Close — Range —
Q1 2014
Shares 73,341 Value ($000) $1,250 Avg Close — Range —
Q4 2013
Shares 715,273 Value ($000) $9,262 Avg Close — Range —
Q3 2013
Shares 504,067 Value ($000) $5,091 Avg Close — Range —
Q2 2013
Shares 691,624 Value ($000) $5,167 Avg Close — Range —